TARDBP and amyotrophic lateral sclerosis: Finally, we suggest that future studies take full advantage of zebrafish in a whole organism compound screening, advancing the opTDP-43-based zebrafish ALS model into a system for screening small molecules that mitigate toxic TDP-43 phase transition for developing effective ALS therapeutics.